MAXTIA: A high‐throughput platform for rapid functional epitope mapping by kinetic screening of mutant libraries
Kihoon Kim, Ryo Matsunaga, Takanori Yokoo, Makoto Nakakido, Kouhei Tsumoto · 2026
Read MAXTIA: A high‐throughput platform for rapid functional epitope mapping by kinetic screening of mutant libraries by Kihoon Kim, Ryo Matsunaga, Takanori Yokoo, Makoto Nakakido, Kouhei Tsumoto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479966.txt.
Description
Kihoon Kim and co-authors published a 2026 paper on a platform that maps where antibodies grab their targets, fast. Knowing the exact patch, the epitope, is essential for designing biologic drugs and understanding immunity. Lab mapping residue by residue is slow; computer prediction of interfaces is unreliable. Their platform, MAXTIA, industrializes the experimental route.
It pairs cell-free protein synthesis, proteins made without living cells, with high-throughput surface plasmon resonance, a sensor that watches binding in real time. Libraries of mutants, each with one residue swapped, are produced and kinetically screened: up to 384 variants in a run. The residues whose swap kills binding mark the functional epitope. Speed changes what is feasible: whole interfaces mapped in days instead of months. The authors demonstrate the workflow on alanine scanning, the standard probe. For drug developers, faster epitope maps mean faster antibody engineering.
Catalog record
| CREATOR | Kihoon Kim, Ryo Matsunaga, Takanori Yokoo, Makoto Nakakido, Kouhei Tsumoto |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |